Clinical syndromes: Parkinsonian gait

Movement Disorders

Volumn 28, Issue 11, 2013, Pages 1552-1559

  Ebersbach, Georg ^a   Moreau, Caroline ^b   Gandor, Florin ^a   Defebvre, Luc ^b   Devos, David ^b  

^a Movement Disorder Clinic   (Germany)

^b UNIV LILLE   (France)

Author keywords

Atypical Parkinsonism; Falls; Gait; Parkinson's disease

Indexed keywords

DONEPEZIL; DOPAMINE; LEVODOPA; METHYLPHENIDATE;

ATAXIC GAIT; BRAIN DEPTH STIMULATION; DRUG MEGADOSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GAIT; GAIT APRAXIA; GAIT DISORDER; HORMONE SUBSTITUTION; HUMAN; HYPOKINESIA; MULTICENTER STUDY (TOPIC); PARKINSON DISEASE; PARKINSONISM; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SHUFFLING GAIT; UNIFIED PARKINSON DISEASE RATING SCALE;

ATYPICAL PARKINSONISM; FALLS; GAIT; PARKINSON'S DISEASE;

ACCIDENTAL FALLS; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; FREEZING REACTION, CATALEPTIC; GAIT DISORDERS, NEUROLOGIC; HUMANS; PARKINSON DISEASE;

EID: 84885795744     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25675     Document Type: Review

References (91)

1. Ebersbach G, Sojer M, Müller J, et al. Sociocultural differences in gait. Mov Disord 2000;15:1145-1147.
2. Ebersbach G, Sojer M, Valldeoriola F, et al. Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. Brain 1999;122:1349-1355.
3. Morris ME, Iansek R, Matyas TA, et al. The pathogenesis of gait hypokinesia in Parkinson's disease. Brain 1994;117:1169-1181.
4. Morris ME, Iansek R, Matyas TA, et al. Stride length regulation in Parkinson's disease. Normalization strategies and underlying mechanisms. Brain. 1996;119:551-568.
5. Baltadjieva R, Giladi N, Gruendlinger L, at al. Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease. Eur J Neurosci 2006;24:1815-1820.
6. Ebersbach G, Heijmenberg M, Kindermann L, et al. Interference of rhythmic constraint on gait in healthy subjects and patients with early Parkinson's disease: evidence for impaired locomotor pattern generation in early Parkinson's disease. Mov Disord 1999;14:619-625.
7. Hausdorff JM, Cudkowicz ME, Firtion R, et al. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease. Mov Disord 1998;13:428-437.
8. Cantiniaux S, Vaugoyeau M, Robert D, et al. Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders? J Neurol Neurosurg Psychiatry 2010;81:177-184.
9. Rochester L, Burn DJ, Woods G, et al. Does auditory rhythmical cueing improve gait in people with Parkinson's disease and cognitive impairment? A feasibility study. Mov Disord 2009;24:839-845.
10. Hely MA, Morris JGL, Reid WGJ, et al. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005;20:190-199.
11. Kempster PA, Williams DR, Selikhova M, et al. Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain 2007;130:2123-2128.
12. Müller ML, Frey KA, Petrou M, et al. β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Mov Disord 2013;28:296-301.
13. Bloem BR, Hausdorff JM, Visser JE, et al. Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord 2004;19:871-884.
14. Giladi N, Nieuwboer A. Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage. Mov Disord 2008;23(SUPPL 2):S423-S425.
15. Nutt JG, Bloem BR, Giladi N, et al. Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol 2011;10:734-744.
16. Giladi N, McDermott MP, Fahn S, et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 2001;56:1712-1721.
17. Macht M, Kaussner Y, Möller JC, et al. Predictors of freezing in Parkinson's disease: a survey of 6, 620 patients. Mov Disord 2007;22:953-956.
18. Ashburn A, Stack E, Pickering RM, Ward CD. Predicting fallers in a community-based sample of people with Parkinson's disease. Gerontology 2001;47:277-281.
19. Gray P, Hildebrand K. Fall risk factors in Parkinson's disease. J Neurosci Nurs 2000;32:222-228.
20. Bloem BR, Grimbergen YA, Cramer M, et al. Prospective assessment of falls in Parkinson's disease. J Neurol 2001;248:950-958.
21. Wood BH, Bilclough JA, Bowron A, et al. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry 2002;72:721-725.
22. Giladi N, Kao R, Fahn S. Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord 1997;12:302-305.
23. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837-844.
24. Latt MD, Lord SR, Morris JG, Fung VS. Clinical and physiological assessments for elucidating falls risk in Parkinson's disease. Mov Disord 2009;24:1280-1289.
25. Mak MK, Pang MY. Parkinsonian single fallers versus recurrent fallers: different fall characteristics and clinical features. J Neurol 2010;257:1543-1551.
26. Amboni M, Cozzolino A, Longo K, et al. Freezing of gait and executive functions in patients with Parkinson's disease. Mov Disord 2008;23:395-400.
27. Naismith SL, Shine JM, Lewis SJG. The specific contributions of set-shifting to freezing of gait in Parkinson's disease. Mov Disord 2010;25:1000-1004.
28. Giladi N, Hausdorff JM. The role of mental function in the pathogenesis of freezing of gait in Parkinson's disease. J Neurol Sci 2006;248:173-176.
29. Snijders AH, Warrenburg BPVD, Giladi N, Bloem BR. Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol 2007;6:63-74.
30. Kostic VS, Agosta F, Pievani M, et al. Pattern of brain tissue loss associated with freezing of gait in Parkinson disease. Neurology 2012;78:409-416.
31. Hallett M. The intrinsic and extrinsic aspects of freezing of gait. Mov Disord 2008;23(SUPPL 2):S439-S443.
32. Ebersbach G, Sojer M, Müller J, et al. [Dysequilibrium in idiopathic Parkinson disease. The effect of cerebrovascular comorbidity]. Nervenarzt 2002;73:162-165.
33. Abdo WF, Borm GF, Munneke M, et al. Ten steps to identify atypical parkinsonism. J Neurol Neurosurg Psychiatry 2006;77:1367-1369.
34. Rochester L, Hetherington V, Jones D, et al. Attending to the task: interference effects of functional tasks on walking in Parkinson's disease and the roles of cognition, depression, fatigue, and balance. Arch Phys Med Rehabil 2004;85:1578-1585.
35. Cole MW, Schneider W. The cognitive control network: Integrated cortical regions with dissociable functions. Neuroimage 2007;37:343-360.
36. Shine JM, Matar E, Ward PB, et al. Differential neural activation patterns in patients with Parkinson's disease and freezing of gait in response to concurrent cognitive and motor load. PLoS One 2013;8:e52602.
37. Snijders AH, Leunissen I, Bakker M, et al. Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait. Brain 2011;134:59-72.
38. Jahn K, Deutschländer A, Stephan T, et al. Imaging human supraspinal locomotor centers in brainstem and cerebellum. Neuroimage 2008;39:786-792.
39. La Fougère C, Zwergal A, Rominger A, et al. Real versus imagined locomotion: a [18F]-FDG PET-fMRI comparison. Neuroimage 2010;50:1589-1598.
40. Zwergal A, la Fougère C, Lorenzl S, et al. Functional disturbance of the locomotor network in progressive supranuclear palsy. Neurology 2013;80:634-641.
41. Tessitore A, Amboni M, Cirillo G, et al. Regional gray matter atrophy in patients with Parkinson disease and freezing of gait. AJNR Am J Neuroradiol 2012;33:1804-1809.
42. Almeida QJ, Lebold CA. Freezing of gait in Parkinson's disease: a perceptual cause for a motor impairment? J Neurol Neurosurg Psychiatry 2010;81:513-518.
43. Cohen RG, Chao A, Nutt JG, et al. Freezing of gait is associated with a mismatch between motor imagery and motor execution in narrow doorways, not with failure to judge doorway passability. Neuropsychologia 2011;49:3981-3988.
44. Berardelli A, Wenning GK, Antonini A, et al. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol 2013;20:16-34.
45. McKeith IG, Dickson D, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-1872.
46. Wenning GK, Ben Shlomo Y, Magalhães M, et al. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994;117:835-845.
47. Gilman S, Wenning GK, Low P, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-676.
48. Nath U, Ben-Shlomo Y, Thomson RG, et al. Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 2003;60:910-916.
49. Williams DR, Holton JL, Strand K, et al. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 2007;22:2235-2241.
50. Armstrong MJ, Litvan I, Lang A, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013;80:496-503.
51. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999;56:98-102.
52. Stolze H, Kuhtz-Buschbeck JP, Drücke H, et al. Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:289-297.
53. Wenning GK, Ebersbach G, Verny M, et al. Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord 1999;14:947-950.
54. Ebersbach G, Gunkel M. Posturography reflects clinical imbalance in Parkinson's disease. Mov Disord 2011;26:241-246.
55. Fahn S. Does levodopa slow or hasten the rate of progression of Parkinson's disease? J Neurol 2005;252(Suppl):IV37-IV42.
56. Espay AJ, Fasano A, van Nuenen BFL, et al. "On" state freezing of gait in Parkinson disease: a paradoxical levodopa-induced complication. Neurology 2012;78:454-457.
57. Moreau C, Delval A, Defebvre L, et al. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol 2012;11:589-596.
58. Nutt JG, Carter JH, Sexton GJ. The dopamine transporter: importance in Parkinson's disease. Ann Neurol 2004;55:766-773.
59. Pollak P, Dobronesky Y, Prohorov T, et al. Low doses methylphenidate improves freezing in advanced Parkinson's disease during off-state. J Neural Transm SUPPL 2007;72:145-148.
60. Devos D, Krystkowiak P, Clement F, et al. Improvement of gait by chronic high doses of methylphenidate in patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:470-475.
61. Auriel E, Haussdorff JM, Giladi N. Methylphenidate for the treatment of Parkinson's disease and other neurological disorders. Clin Neuropharmacol 2009;32:75-81.
62. Espay AJ, Dwivedi AK, Payne L, et al. Methylphenidate for gait impairment in Parkinson's disease: a randomized clinical trial. Neurology 2011;76:1256-1262.
63. Nutt JG, Carter JH, Carlson NE. Effects of methylphenidate on response to oral levodopa; a double blind-clinical trial Arch Neurol 2007;64:319-323.
64. Moreau C, Delval A, Tiffreau V, et al. Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study. J Neurol Neurosurg Psychiatry 2013;84:552-555.
65. Chung KA, Lobb BM, Nutt JG, et al. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 2010;75:1263-1269.
66. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
67. Zibetti M, Merola A, Rizzi L, et al. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease. Mov Disord 2011;26:2327-2334.
68. Schuepbach WM, Rau J, Knudsen K, et al; EARLYSTIM Study Group. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 2013;368:610-622.
69. Moreau C, Defebvre L, Destée A, et al. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology 2008;71:80-84.
70. Niu L, Ji L-Y, Li J-M, et al. Effect of bilateral deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease. J Int Med Res 2012;40:1108-1113.
71. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005;128:2240-2249.
72. Muniz AMS, Nadal J, Lyons KE, et al. Long-term evaluation of gait initiation in six Parkinson's disease patients with bilateral subthalamic stimulation. Gait Posture 2012;35:452-457.
73. Hilliard JD, Frysinger RC, Elias WJ. Effective subthalamic nucleus deep brain stimulation sites may differ for tremor, bradykinesia and gait disturbances in Parkinson's disease. Stereotact Funct Neurosurg 2011;89:357-364.
74. Xie T, Kang UJ, Warnke P. Effect of stimulation frequency on immediate freezing of gait in newly activated STN DBS in Parkinson's disease. J Neurol Neurosurg Psychiatry 2012;83:1015-1017.
75. Nieuwboer A, Kwakkel G, Rochester L, et al. Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry 2007;78:134-140.
76. Jöbges M, Heuschkel G, Pretzel C, et al. Repetitive training of compensatory steps: a therapeutic approach for postural instability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;75:1682-1687.
77. Ebersbach G, Ebersbach A, Edler D, et al. Comparing exercise in Parkinson's disease-the Berlin LSVT®BIG study. Mov Disord 2010;25:1902-1908.
78. Li F, Harmer P, Fitzgerald K, et al. Tai chi and postural stability in patients with Parkinson's disease. N Engl J Med 2012;366:511-519.
79. Goodwin VA, Richards SH, Henley W, et al. An exercise intervention to prevent falls in people with Parkinson's disease: a pragmatic randomised controlled trial. J Neurol Neurosurg Psychiatry 2011;82:1232-1238.
80. Fukada K, Endo T, Yokoe M, et al. L-threo-3, 4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson's disease. Med Hypotheses 2013;80:209-212.
81. Mazzone P, Lozano A, Stanzione P, et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport 2005;16:1877-1881.
82. Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport 2005;16:1883-1887.
83. Stefani A, Lozano AM, Peppe A, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007;130:1596-1607.
84. Moro E, Hamani C, Poon Y-Y, et al. Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain 2010;133:215-224.
85. Ferraye MU, Debû B, Fraix V, et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010;133:205-214.
86. Fisher BE, Wu AD, Salem GJ, et al. The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease. Arch Phys Med Rehabil 2008;89:1221-1229.
87. Hirsch MA, Farley BG. Exercise and neuroplasticity in persons living with Parkinson's disease. Eur J Phys Rehabil Med 2009;45:215-229.
88. Petzinger GM, Fisher BE, van Leeuwen J-E, et al. Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson's disease. Mov Disord 2010;25(SUPPL 1):S141-S145.
89. Kleim JA, Jones TA, Schallert T. Motor enrichment and the induction of plasticity before or after brain injury. Neurochem Res 2003;28:1757-1769.
90. Kleim JA, Jones TA. Principles of experience-dependent neural plasticity: implications for rehabilitation after brain damage. J Speech Lang Hear Res 2008;51:S225-S239.
91. Ahlskog JE. Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology 2011;77:288-294.